The NALP3 inflammasome is involved in the innate immune response to amyloid-β-Reference-Cited by-同舟云学术

The NALP3 inflammasome is involved in the innate immune response to amyloid-β

Published:2008-07-11 Issue:8 Volume:9 Page:857-865
ISSN:1529-2908
Container-title:Nature Immunology
language:en
Short-container-title:Nat Immunol

Author:

Halle Annett,Hornung Veit,Petzold Gabor C,Stewart Cameron R,Monks Brian G,Reinheckel Thomas,Fitzgerald Katherine A,Latz Eicke,Moore Kathryn J,Golenbock Douglas T

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy

Link

http://www.nature.com/articles/ni.1636.pdf

Reference47 articles.

1. Weiner, H.L. & Frenkel, D. Immunology and immunotherapy of Alzheimer's disease. Nat. Rev. Immunol. 6, 404–416 (2006).

2. Meyer-Luehmann, M. et al. Rapid appearance and local toxicity of amyloid-β plaques in a mouse model of Alzheimer's disease. Nature 451, 720–724 (2008).

3. Simard, A.R., Soulet, D., Gowing, G., Julien, J.P. & Rivest, S. Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease. Neuron 49, 489–502 (2006).

4. Itagaki, S., McGeer, P.L., Akiyama, H., Zhu, S. & Selkoe, D. Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease. J. Neuroimmunol. 24, 173–182 (1989).

5. Weggen, S. et al. A subset of NSAIDs lower amyloidogenic Aβ42 independently of cyclooxygenase activity. Nature 414, 212–216 (2001).

Cited by 2043 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inflammation and gut microbiota in the alcoholic liver disease;Food & Medicine Homology;2024-12

2. Recent updates on immunotherapy in neurodegenerative diseases;Brain Research;2024-12

3. Fecal microbiome transplantation alleviates manganese-induced neurotoxicity by altering the composition and function of the gut microbiota via the cGAS–STING/NLRP3 pathway;Science of The Total Environment;2024-11

4. Potential Impact of Bioactive Compounds as NLRP3 Inflammasome Inhibitors: An Update;Current Pharmaceutical Biotechnology;2024-10

5. Complement 3a induces the synapse loss via C3aR in mitochondria-dependent NLRP3 activating mechanisms during the development and progression of Alzheimer’s disease;Neuroscience & Biobehavioral Reviews;2024-10